appears in the following:

Encore: Infusions of antibodies used to treat COVID are being phased out

Wednesday, November 30, 2022

More than 3.5 million infusions of antibodies have been used to treat COVID. The treatment is being phased out because the antibodies have lost their efficacy against new variants of coronavirus.


The disease formerly known as monkeypox has a new name

Monday, November 28, 2022

The disease formerly known as monkeypox has a new name: "mpox." It's not much of a depature, but it's less stigmatizing, according to advocates who have been calling for a change of name.


How monoclonal antibodies lost the fight with new COVID variants

Sunday, November 20, 2022

The treatments were highly popular earlier in the pandemic. One by one, they got knocked out by more convenient, less expensive treatment options, and new COVID variants.


New VA study finds Paxlovid may cut the risk of long COVID

Tuesday, November 08, 2022

For those at high risk, Pfizer's antiviral drug helps stave off severe COVID-19. Now research suggests it may also reduce their chances of long COVID.


CDC issues new opioid prescribing guidance, giving doctors more leeway to treat pain

Thursday, November 03, 2022

The updated recommendations seek to course correct after guidelines from 2016 were criticized for harshly limiting access to needed pain medication.


CDC underscores the importance of Black and Hispanic adults getting flu shots

Wednesday, October 19, 2022

About half of U.S. adults get their flu shot each year, but a new report finds that Black, Hispanic and Native Americans are less likely to get a flu vaccine — and more likely to be hospitalized.


Monkeypox cases in the U.S. are way down — can the virus be eliminated?

Monday, October 17, 2022

Early fears of an escalating outbreak have not come to pass. Scientists are finding that the virus needs a very particular set of circumstances to spread effectively.


Monkeypox cases in the U.S. have been falling since a peak in early August

Tuesday, October 11, 2022

New daily monkeypox cases have been falling, and the CDC says cases are probably going to plateau or decline over the next few weeks.


Senators grill top health agencies on the U.S. response to monkeypox

Thursday, September 15, 2022

In the first congressional hearing on monkeypox, federal officials were criticized for being slow to act, and struggling to apply the lessons of the pandemic to the current outbreak.


What happened in the Senate's hearing on the federal response to monkeypox

Wednesday, September 14, 2022

Congress held its hearing on the federal response to the monkeypox outbreak. That comes as cases — and vaccinations — slow down in the U.S.


The top White House monkeypox doc takes stock of the outbreak — and what's next

Monday, September 12, 2022

Dr. Demetre Daskalakis is steering the U.S. monkeypox response. A month into the job, he sees signs of success, but there's still more to be done.


Puzzling trend: large proportion of monkeypox cases have happened in people with HIV

Friday, September 09, 2022

A new report from the Centers for Disease Control and Prevention finds that a disproportionate number of people who are contracting monkeypox in the U.S. are also HIV-positive.


Early signs suggest monkeypox may be slowing in the U.S.

Friday, August 26, 2022

Rates of new cases are declining in major cities, suggesting public health campaigns are working.


When did human bodies evolve to sweat? We don't know exactly when

Thursday, August 25, 2022

All summer, NPR's Science Desk has been looking at sweat. Humans are covered with millions of sweat glands, but it wasn't always that way. When did humans start to sweat?


Pfizer asks FDA to greenlight new omicron booster shots, which could arrive this fall

Monday, August 22, 2022

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.


The new U.S. monkeypox vaccine strategy offers more doses — and uncertainty

Friday, August 19, 2022

Missteps and delays have hampered the U.S. effort to vaccinate people against monkeypox. Now state health officials and community members are trying to adapt to a controversial "dose sparing" plan.


Facing a monkeypox vaccines shortage, the U.S. is pursuing a new dosing strategy

Thursday, August 18, 2022

The U.S. is facing a shortage of the monkeypox vaccine as the outbreak grows rapidly. The White House is pursuing a controversial strategy where each person only gets a fraction of the full dose.


CDC's new guidance ends test-to-stay for schools and relaxes COVID rules

Friday, August 12, 2022

The CDC stopped recommending quarantines or test-to-stay in schools. It's part of a relaxation of COVID guidance that acknowledges the virus is here to stay, and that many people have prior immunity.


With new guidance, CDC ends test-to-stay for schools and relaxes COVID rules

Thursday, August 11, 2022

Revised guidance from the Centers for Disease Control and Prevention looks to minimize COVID-19's disruption of daily life while conceding that the pandemic isn't over.


With supplies low, FDA authorizes plan to stretch limited monkeypox vaccine doses

Tuesday, August 09, 2022

The Biden administration is allowing the shot to be given between layers of skin — a method that only requires a fifth of the full dose — in order to increase vaccinations and slow the outbreak.